Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Using index funds to manage risk emphasizes broad diversification and low costs. These funds help smooth returns and reduce exposure to idiosyncratic losses.
27,240 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A major hedge fund reduced its Indivior stake by more than 2.2 million shares, signaling a shift in positioning. This...
Regulators are pressing for clearer access and safer custody as major venues reshape how crypto trades are executed. ...
Pfizer currently draws attention for its high dividend yield, but a big payout can mask risk. This guide explains how...
A 19% correction can spark questions about buying gold. This guide breaks down what history says, weighs physical gol...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
Gold prices surged last year and pulled back from a record. This guide helps you decide if you should gold while it's...
A revealing look at how the crypto world got swept up in an illusion of money and momentum. Learn what happened, why ...
A Texas Capital BancShares board member purchased 1,000 shares at $91.50 per share as the stock price weakened. This ...
A practical, scenario-driven look at predicting where SpaceX headed by 2026 and how investors can approach this high-...
Choosing between IXJ and PINK comes down to strategy, costs, and risk tolerance. This guide breaks down how each ETF ...
An investor group disclosed a $3.5 million stake in Avantor as the stock slipped more than half. This article breaks ...